Benzinga's Top Upgrades, Downgrades For December 22, 2016

Top Upgrades

• Analysts at Summit Redstone Partners upgraded Micron Technology, Inc. MU from Sell to Buy. Micron shares rose 12.05 percent to $23.06 in pre-market trading.
• Baird upgraded AMETEK, Inc. AME from Neutral to Outperform. AMETEK shares fell 0.34 percent to close at $49.30 on Wednesday.
• Citigroup upgraded Merus NV MRUS from Neutral to Buy. Merus shares gained 0.40 percent to $20.30 in pre-market trading.
• FBR Capital upgraded Sunoco LP SUN from Market Perform to Outperform. Sunoco shares rose 6.32 percent to close at $23.54 on Wednesday.
• Analysts at Mizuho upgraded Sucampo Pharmaceuticals, Inc. SCMP from Neutral to Buy. Sucampo Pharmaceuticals shares rose 0.78 percent to $12.95 in pre-market trading.
• Needham & Company upgraded Micron Technology MU from Underperform to Buy. Micron shares rose 12.05 percent to $23.06 in pre-market trading.
• Analysts at Baird upgraded National Instruments Corp NATI from Neutral to Outperform. National Instruments shares fell 0.46 percent to close at $30.06 on Wednesday.

Top Downgrades

• SunTrust Robinson Humphrey downgraded Procter & Gamble Co PG from Buy to Hold. Procter & Gamble shares fell 0.50 percent to $83.86 in pre-market trading.
• Analysts at Wells Fargo downgraded Swift Transportation Co SWFT from Outperform to Market Perform. Swift Transportation shares fell 0.49 percent to close at $24.48 on Wednesday.
• BMO Capital downgraded Greif, Inc. GEF from Market Perform to Underperform. Greif shares fell 0.57 percent to close at $53.81 on Wednesday.
• Raymond James downgraded Bed Bath & Beyond Inc. BBBY from Strong Buy to Market Perform. Bed Bath & Beyond shares fell 4.39 percent to $43.56 in pre-market trading.
• Analysts at B. Riley downgraded Stage Stores Inc SSI from Neutral to Sell. Stage Stores shares fell 0.56 percent to close at $5.31 on Wednesday.
• Stifel Nicolaus downgraded Red Hat Inc RHT from Buy to Hold. Red Hat shares fell 12.06 percent to $70.17 in pre-market trading.
• Analysts at Canaccord Genuity downgraded Finish Line Inc FINL from Buy to Hold. Finish Line shares fell 2.67 percent to $20.44 in pre-market trading.
• Pacific Crest downgraded InvenSense Inc INVN from Overweight to Sector Weight. InvenSense shares fell 0.08 percent to $12.74 in pre-market trading.
• B. Riley downgraded Zumiez Inc. ZUMZ from Buy to Neutral. Zumiez shares fell 2.41 percent to $22.25 in pre-market trading.

Top Initiations

• Analysts at BTIG Research initiated coverage on CoLucid Pharmaceuticals Inc CLCD with a Buy rating. The price target for CoLucid Pharmaceuticals is set to $58. CoLucid Pharmaceuticals shares closed at $36.15 on Wednesday.
• Analysts at JP Morgan initiated coverage on Sarepta Therapeutics Inc SRPT with an Overweight rating. The price target for Sarepta Therapeutics is set to $40. Sarepta Therapeutics shares closed at $29.49 on Wednesday.
• Analysts at Drexel Hamilton initiated coverage on Power Integrations Inc POWI with a Buy rating. Power Integrations shares closed at $67.65 on Wednesday.
• Analysts at BMO Capital initiated coverage on Healthcare Realty Trust Inc HR with a Market Perform rating. The price target for Healthcare Realty Trust is set to $31. Healthcare Realty Trust shares closed at $29.39 on Wednesday.
• Analysts at Raymond James initiated coverage on Flexion Therapeutics Inc FLXN with a Strong Buy rating. Flexion Therapeutics shares closed at $18.18 on Wednesday.
• Analysts at Guggenheim initiated coverage of Akamai Technologies, Inc. AKAM with a Buy rating. The price target for Akamai Technologies is set to $75. Akamai Technologies shares closed at $67.87 on Wednesday.
• Analysts at Piper Jaffray initiated coverage on Microsoft Corporation MSFT with an Overweight rating. The price target for Microsoft is set to $80. Microsoft shares closed at $63.54 on Wednesday.
• Jefferies initiated coverage on Radware Ltd. RDWR with a Buy rating. The price target for Radware is set to $18.50. Radware shares closed at $14.31 on Wednesday.
• Aegis Capital initiated coverage on Wynn Resorts, Limited WYNN with a Neutral rating. The price target for Wynn Resorts is set to $87. Wynn Resorts shares closed at $89.27 on Wednesday
• Leerink Swann initiated coverage on Cardiome Pharma Corp CRME with an Outperform rating. Cardiome Pharma shares closed at $2.70 on Wednesday.